Lead optimization and preclinical development of human nicotine-specific mabs
Ended Project Grant Awarded Last action
- Award ID
- R01DA038877
- Recipient
-
Antidote Therapeutics Inc. UEI KNPKVDXDCNL9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,453,608
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- Westlake, MD 20817, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $2,939,717 | |
| Amendment | $2,960,853 | |
| Amendment | $48,734 | |
| Original award | $2,504,304 |
Quick answers
Who received award R01DA038877?
R01DA038877 was awarded to Antidote Therapeutics Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2014.
How much is award R01DA038877 worth?
$8,453,608 has been obligated on R01DA038877.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award